CTRI/2021/11/037721尚未招募未知
Impact of gut decontamination by rifaximin in patients with predicted severe acute pancreatitis: A pilot study
Department of gastroenterology and heaptology0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with a diagnosis of Predicted acute pancreatitis as per Atlanta classification presenting within seven days of pain onset
- •Patients with a diagnosis of Predicted acute pancreatitis as per Atlanta classification presenting within seven days of pain onset
- •Age >18 years
- •With one of the following:
- •1.Predicted Severe acute pancreatitis indicated by 3 or more points according to Imrie score
- •2.Atlanta classifification
- •3.and/or CECT Abdomen findings of Balthazar grade D or E
排除标准
- •1.Previous history of allergy to Rifaximin
- •2.Patient with pancreatic malignancy
- •3.Postoperative pancreatitis after pancreatic surgery Bacteriologically proved infected necrosis at the time of randomization
研究者
相似试验
进行中（未招募）
不适用
Intestinal decontamination with rifaximiiver cirrhosis of any etilogy, complicated by decompensation and classified as Child-Pugh B or CMedDRA version: 17.1Level: LLTClassification code 10024667Term: Liver cirrhosisSystem Organ Class: 100000004871EUCTR2012-002890-71-DKFlemming Bendtsen
已完成
4 期
Intestinal Decontamination With Rifaximin. The Inflammatory and Circulatory State in Patients With CirrhosisAscitesLiver CirrhosisNCT01769040Copenhagen University Hospital, Hvidovre54
撤回
不适用
The Effect of Gut Sterilisation on the Prevention of Progression of Portal Hypertension in Cirrhosis.iver cirrhosisPortal hypertensionVariceal bleedingACTRN12617000184370Royal Adelaide Hospital10
已完成
不适用
The effect of rifaximin on small intestinal motility and microbiota in patients with liver cirrhosisiver cirrhosisJPRN-UMIN000028986Division of Gastroenterology and Hepatology, Graduate School of Medical and Dental Sciences, Niigata University20
进行中（未招募）
1 期
Effect of administration of Rifaximin on the increased portal pressure of patients with liver cirrhosis and esophageal varices already treated with propranololEUCTR2014-000102-35-ITClinica Medica 560